A review of antioxidants and Alzheimer's disease.

BACKGROUND In this article, we review a diverse body of research and draw conclusions about the usefulness, or lack there-of, of specific antioxidants in the prevention of Alzheimer's disease (AD). METHODS The National Library of Medicine's database was searched for the years 1996-2004 using the search terms "Alzheimer's, anti-oxidants, antioxidants." RESULTS Over 300 articles were identified and 187 articles were selected for inclusion based on relevance to the topic. Agents that show promise in helping prevent AD include: 1) aged garlic extract, 2) curcumin, 3) melatonin, 4) resveratrol, 5) Ginkgo biloba extract, 6) green tea, 7) vitamin C and 8) vitamin E. CONCLUSIONS While the clinical value of antioxidants for the prevention of AD is often ambiguous, some can be recommended based upon: 1) epidemiological evidence, 2) known benefits for prevention of other maladies, and 3) benign nature of the substance. Long-term, prospective studies are recommended.

[1]  M. Mulero,et al.  Aluminum‐induced pro‐oxidant effects in rats: protective role of exogenous melatonin , 2003, Journal of pineal research.

[2]  B. Ames,et al.  Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: Partial reversal by feeding acetyl-l-carnitine and/or R-α-lipoic acid , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[3]  D. Ashline,et al.  Homocysteine potentiates β‐amyloid neurotoxicity: role of oxidative stress , 2001 .

[4]  R. Reiter,et al.  An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease , 2000, Journal of Neural Transmission.

[5]  Bing-sheng Li,et al.  α-lipoic acid protects rat cortical neurons against cell death induced by amyloid and hydrogen peroxide through the Akt signalling pathway , 2001, Neuroscience Letters.

[6]  S. Nah,et al.  Protective effect of ginsenosides, active ingredients of Panax ginseng, on kainic acid-induced neurotoxicity in rat hippocampus , 2002, Neuroscience Letters.

[7]  G. M. Cole,et al.  Phenolic anti-inflammatory antioxidant reversal of Aβ-induced cognitive deficits and neuropathology , 2001, Neurobiology of Aging.

[8]  C. P. Maurizi Alzheimer's disease: roles for mitochondrial damage, the hydroxyl radical, and cerebrospinal fluid deficiency of melatonin. , 2001, Medical hypotheses.

[9]  S. Kulkarni,et al.  Possible antioxidant mechanism in melatonin reversal of aging and chronic ethanol-induced amnesia in plus-maze and passive avoidance memory tasks. , 2001, Free radical biology & medicine.

[10]  E. Cho,et al.  Ginsenoside‐Rd attenuates oxidative damage related to aging in senescence‐accelerated mice , 2004, The Journal of pharmacy and pharmacology.

[11]  S. Mandel,et al.  Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures. , 2002, Biochemical pharmacology.

[12]  J. Joseph,et al.  A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: a multiplicity of effects. , 2001, Free radical biology & medicine.

[13]  J. Mix,et al.  A double‐blind, placebo‐controlled, randomized trial of Ginkgo biloba extract EGb 761® in a sample of cognitively intact older adults: neuropsychological findings , 2002, Human psychopharmacology.

[14]  J. Pettegrew,et al.  Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression , 2000, Molecular Psychiatry.

[15]  N. P. Kedar Can we prevent Parkinson's and Alzheimer's disease? , 2003, Journal of postgraduate medicine.

[16]  Y. Christen,et al.  Amyloid precursor protein metabolism is regulated toward alpha-secretase pathway by Ginkgo biloba extracts , 2004, Neurobiology of Disease.

[17]  Y. Gupta,et al.  Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats. , 2002, Life sciences.

[18]  Taeck-Hyun Lee,et al.  Effect of ginseng radix on c-Fos expression in the hippocampus of streptozotocin-induced diabetic rats. , 2003, Journal of pharmacological sciences.

[19]  P. Schultz,et al.  Age-related effects of Ginkgo biloba extract on synaptic plasticity and excitability , 2004, Neurobiology of Aging.

[20]  A. Hofman,et al.  Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. , 2004, Archives of neurology.

[21]  T. Sasaoka,et al.  Antioxidant effects of tetrahydro‐β‐carboline derivatives identified in aged garlic extract , 2002, BioFactors.

[22]  I. Bourdel-Marchasson,et al.  Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients. , 2001, Age and ageing.

[23]  R. Quirion,et al.  Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide‐related toxicity in cultured hippocampal neurons , 2000, British journal of pharmacology.

[24]  P. Knipschild,et al.  The Efficacy of Ginkgo for Elderly People with Dementia and Age‐Associated Memory Impairment: New Results of a Randomized Clinical Trial , 2000, Journal of the American Geriatrics Society.

[25]  P. Agostinho,et al.  Involvement of oxidative stress in the enhancement of acetylcholinesterase activity induced by amyloid beta-peptide , 2003, Neuroscience Research.

[26]  K. Davies,et al.  Mitochondrial free radical generation, oxidative stress, and aging. , 2000, Free radical biology & medicine.

[27]  L. Thal,et al.  Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease , 2003, International clinical psychopharmacology.

[28]  I. Young,et al.  Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease. , 1999, QJM : monthly journal of the Association of Physicians.

[29]  Debomoy K Lahiri,et al.  Dietary supplementation with melatonin reduces levels of amyloid beta‐peptides in the murine cerebral cortex , 2004, Journal of pineal research.

[30]  Deborah Gustafson,et al.  Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. , 2004, Archives of neurology.

[31]  R. Reiter,et al.  Melatonin and mitochondrial function. , 2004, Life sciences.

[32]  H. Gertz,et al.  Review about Ginkgo biloba special extract EGb 761 (Ginkgo). , 2003, Current pharmaceutical design.

[33]  M. Trabucchi,et al.  Effects of acetyl-L-carnitine in Alzheimer's disease patients unresponsive to acetylcholinesterase inhibitors. , 2003, Current medical research and opinion.

[34]  Koji Abe,et al.  Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease , 2003, Journal of neurochemistry.

[35]  J. Muñoz-Castañeda,et al.  Comparison of melatonin versus vitamin C on oxidative stress and antioxidant enzyme activity in Alzheimer's disease induced by okadaic acid in neuroblastoma cells. , 2002, European journal of pharmacology.

[36]  Q. Peng,et al.  Neuroprotective effect of garlic compounds in amyloid-beta peptide-induced apoptosis in vitro. , 2002, Medical science monitor : international medical journal of experimental and clinical research.

[37]  A. Sachinidis,et al.  Molecular mechanisms explaining the preventive effects of catechins on the development of proliferative diseases. , 2004, Current pharmaceutical design.

[38]  R. Quirion,et al.  EGb 761 is a neuroprotective agent against beta-amyloid toxicity. , 2002, Cellular and molecular biology.

[39]  Y. Christen,et al.  What is Ginkgo biloba extract EGb 761? An overview--from molecular biology to clinical medicine. , 2002, Cellular and molecular biology.

[40]  X. Tang,et al.  Huperzine A improves cognitive deficits caused by chronic cerebral hypoperfusion in rats. , 2000, European journal of pharmacology.

[41]  E. Kapaki,et al.  Ascorbate in healthy subjects, amyotrophic lateral sclerosis and Alzheimer's disease , 1997, Acta neurologica Scandinavica.

[42]  F. V. Defeudis,et al.  Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. , 2000, Current drug targets.

[43]  Antioxidants in Alzheimer's disease-vitamin C delivery to a demanding brain. , 2003, Journal of Alzheimer's disease : JAD.

[44]  G. Taglialatela,et al.  Ascorbic acid prevents β-amyloid-induced intracellular calcium increase and cell death in PC12 cells , 1998, Neuroscience Letters.

[45]  Y. Gupta,et al.  Effect of alpha lipoic acid on intracerebroventricular streptozotocin model of cognitive impairment in rats , 2003, European Neuropsychopharmacology.

[46]  N. Nishiyama,et al.  Ameliorative effect of S-allylcysteine, a major thioallyl constituent in aged garlic extract, on learning deficits in senescence-accelerated mice. , 2001, The Journal of nutrition.

[47]  B. Vellas,et al.  Low plasma vitamin C in Alzheimer patients despite an adequate diet , 1998, International journal of geriatric psychiatry.

[48]  S. Sorbi,et al.  Oxidative stress and reduced antioxidant defenses in peripheral cells from familial Alzheimer's patients. , 2002, Free radical biology & medicine.

[49]  Yukui Zhang,et al.  Melatonin in Chinese medicinal herbs. , 2003, Life sciences.

[50]  D. Foley,et al.  Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia Aging Study. , 2004, American journal of epidemiology.

[51]  S. Suh,et al.  Protective effect of green tea polyphenol (‐)‐epigallocatechin gallate and other antioxidants on lipid peroxidation in gerbil brain homogenates , 2003, Phytotherapy research : PTR.

[52]  L. Beckett,et al.  Vitamin E and Vitamin C Supplement Use and Risk of Incident Alzheimer Disease , 1998, Alzheimer disease and associated disorders.

[53]  Y. Surh,et al.  Effects of Selected Ginsenosides on Phorbol Ester‐Induced Expression of Cyclooxygenase‐2 and Activation of NF‐κB and ERK1/2 in Mouse Skin , 2002, Annals of the New York Academy of Sciences.

[54]  L. Thal,et al.  A 1-year controlled trial of acetyl-l-carnitine in early-onset AD , 2000, Neurology.

[55]  V. Caso,et al.  The Action of Acetyl‐l‐Carnitine on the Neurotoxicity Evoked by Amyloid Fragments and Peroxide on Primary Rat Cortical Neurones , 2001, Annals of the New York Academy of Sciences.

[56]  J. Cai,et al.  Improving effects of huperzine A on spatial working memory in aged monkeys and young adult monkeys with experimental cognitive impairment. , 1999, The Journal of pharmacology and experimental therapeutics.

[57]  R. W. Gracy,et al.  Vitamin E prevents oxidation of antiapoptotic proteins in neuronal cells , 2003, Proteomics.

[58]  R. Martins,et al.  Reduction of inclusion body pathology in ApoE-deficient mice fed a combination of antioxidants. , 2003, Free radical biology & medicine.

[59]  Peter P. Zandi,et al.  Apolipoprotein E ϵ4 Count Affects Age at Onset of Alzheimer Disease,but Not Lifetime Susceptibility: The Cache County Study , 2004 .

[60]  T. Shea,et al.  Acetyl-l-Carnitine Protects Against Amyloid-Beta Neurotoxicity: Roles of Oxidative Buffering and ATP Levels , 2002, Neurochemical Research.

[61]  D. Ruff,et al.  Effect of Aged Garlic Extract on Caspase-3 Activity, In Vitro , 2002, Nutritional neuroscience.

[62]  L. Murphy,et al.  Ginseng, Sex Behavior, and Nitric Oxide , 2002, Annals of the New York Academy of Sciences.

[63]  J. Richardson,et al.  Mitochondria from Alzheimer's fibroblasts show decreased uptake of calcium and increased sensitivity to free radicals. , 1994, Life sciences.

[64]  D. Mckenna,et al.  Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications. , 2001, Alternative therapies in health and medicine.

[65]  Jian Yang,et al.  Huperzine A protects rat pheochromocytoma cells against hydrogen peroxide-induced injury , 1999, Neuroscience Letters.

[66]  T Seal,et al.  Screening of antioxidant activity of three Indian medicinal plants, traditionally used for the management of neurodegenerative diseases. , 2003, Journal of ethnopharmacology.

[67]  K. Kannan,et al.  Oxidative stress and apoptosis. , 2000, Pathophysiology : the official journal of the International Society for Pathophysiology.

[68]  M. Altamirano-Lozano,et al.  Total antioxidant levels, gender, and age as risk factors for DNA damage in lymphocytes of the elderly , 2001, Mechanisms of Ageing and Development.

[69]  P. Mecocci Oxidative stress in mild cognitive impairment and Alzheimer disease: a continuum. , 2004, Journal of Alzheimer's disease : JAD.

[70]  A. Wirz-Justice,et al.  Cerebrovascular melatonin MT1-receptor alterations in patients with Alzheimer's disease , 2001, Neuroscience Letters.

[71]  H. Zhang,et al.  Huperzine A attenuates amyloid β‐peptide fragment 25‐35‐induced apoptosis in rat cortical neurons via inhibiting reactive oxygen species formation and caspase‐3 activation , 2002, Journal of neuroscience research.

[72]  G. Cole,et al.  The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse , 2001, The Journal of Neuroscience.

[73]  Simon Melov,et al.  Endogenous mitochondrial oxidative stress: neurodegeneration, proteomic analysis, specific respiratory chain defects, and efficacious antioxidant therapy in superoxide dismutase 2 null mice , 2003, Journal of neurochemistry.

[74]  R. K. Gordon,et al.  The NMDA receptor ion channel: a site for binding of huperzine A , 2001, Journal of applied toxicology : JAT.

[75]  R. Acquaviva,et al.  Nitric oxide-related toxicity in cultured astrocytes: effect of Bacopa monniera. , 2003, Life sciences.

[76]  L. Thal,et al.  A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease. , 2003, Sleep.

[77]  Y. Sagara,et al.  Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. , 2001, Free radical biology & medicine.

[78]  S. K. Ghosal,et al.  Antioxidant activity ofBacopa monniera in rat frontal cortex, striatum and hippocampus , 2000, Phytotherapy research : PTR.

[79]  E. Esposito,et al.  Biochemical and therapeutic effects of antioxidants in the treatment of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. , 2003, Current drug targets. CNS and neurological disorders.

[80]  Xiongwei Zhu,et al.  Alzheimer disease: evidence for a central pathogenic role of iron-mediated reactive oxygen species. , 2004, Journal of Alzheimer's disease : JAD.

[81]  W. D. Ehmann,et al.  Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain. , 1998, Neurotoxicology.

[82]  E. Melamed,et al.  Antioxidant treatment in alzheimer’s disease , 2003, Journal of Molecular Neuroscience.

[83]  D. Bai,et al.  Stereoselectivities of enantiomers of huperzine A in protection against β-amyloid25–35-induced injury in PC12 and NG108-15 cells and cholinesterase inhibition in mice , 2002, Neuroscience Letters.

[84]  K. Bae,et al.  Green tea catechins as a BACE1 (β-secretase) inhibitor , 2003 .

[85]  D. Butterfield,et al.  The antioxidants α‐lipoic acid and N‐acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice , 2003, Journal of neurochemistry.

[86]  P. Mecocci,et al.  Short-term and long-term vitamin C supplementation in humans dose-dependently increases the resistance of plasma to ex vivo lipid peroxidation. , 2004, Archives of biochemistry and biophysics.

[87]  B. Halliwell,et al.  Increased iron staining in the cerebral cortex of cholesterol fed rabbits , 2004, Mechanisms of Ageing and Development.

[88]  S. Suh,et al.  The green tea polyphenol (−)-epigallocatechin gallate attenuates β-amyloid-induced neurotoxicity in cultured hippocampal neurons , 2001 .

[89]  D. Bai,et al.  Huperzine A, a potential therapeutic agent for treatment of Alzheimer's disease. , 2000, Current medicinal chemistry.

[90]  P. Arivazhagan,et al.  Neurochemical changes related to ageing in the rat brain and the effect of dl-α-lipoic acid , 2002, Experimental Gerontology.

[91]  W. Markesbery,et al.  Protection against amyloid beta peptide and iron/hydrogen peroxide toxicity by alpha lipoic acid. , 2003, Journal of Alzheimer's disease : JAD.

[92]  J. Sastre,et al.  Mitochondrial theory of aging: importance to explain why females live longer than males. , 2003, Antioxidants & redox signaling.

[93]  T. Montine,et al.  Suppression of longitudinal increase in CSF F2-isoprostanes in Alzheimer's disease. , 2004, Journal of Alzheimer's disease : JAD.

[94]  K. Hall,et al.  Association of antioxidants with memory in a multiethnic elderly sample using the Third National Health and Nutrition Examination Survey. , 1999, American journal of epidemiology.

[95]  J. Yesavage,et al.  Acetyl L-Carnitine Slows Decline in Younger Patients With Alzheimer's Disease: A Reanalysis of a Double-Blind, Placebo-Controlled Study Using the Trilinear Approach , 1998, International Psychogeriatrics.

[96]  S. Arlt,et al.  Influence of vitamin E and C supplementation on lipoprotein oxidation in patients with Alzheimer's disease. , 2001, Free radical biology & medicine.

[97]  K. Hensley,et al.  Reactive oxygen species and protein oxidation in aging: a look back, a look ahead. , 2002, Archives of biochemistry and biophysics.

[98]  Y. Naito,et al.  Ginkgo biloba leaf extract: review of biological actions and clinical applications. , 1999, Antioxidants & redox signaling.

[99]  Y. Surh,et al.  Protective effect of resveratrol on β-amyloid-induced oxidative PC12 cell death ☆ , 2003 .

[100]  F. J. Romero,et al.  Lipid peroxidation products and antioxidants in human disease. , 1998, Environmental health perspectives.

[101]  S. Maxwell,et al.  Altered plasma antioxidant status in subjects with Alzheimer's disease and vascular dementia , 1998, International journal of geriatric psychiatry.

[102]  D. Butterfield,et al.  Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. , 2000, Journal of structural biology.

[103]  J. Trojanowski,et al.  Early Vitamin E supplementation in young but not aged mice reduces Aβ levels and amyloid deposition in a transgenic model of Alzheimer's disease , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[104]  T. Tsuneyoshi,et al.  Isolation and characterization of the genes up-regulated in isolated neurons by aged garlic extract (AGE). , 2001, The Journal of nutrition.

[105]  D. Butterfield,et al.  Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: A nutritional approach , 2003, Amino Acids.

[106]  Vijayalaxmi,et al.  Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage. , 2004, Polish journal of pharmacology.

[107]  A. Tappel,et al.  Oxidant free radical initiated chain polymerization of protein and other biomolecules and its relationship to diseases. , 2004, Medical hypotheses.

[108]  Kuresh Youdim,et al.  Roles of vitamins E and C on neurodegenerative diseases and cognitive performance. , 2002, Nutrition reviews.

[109]  H. Steinbusch,et al.  Antioxidants and Alzheimer's disease: from bench to bedside (and back again) , 2002, Current opinion in clinical nutrition and metabolic care.

[110]  S. Shiu,et al.  The effects of melatonin and Ginkgo biloba extract on memory loss and choline acetyltransferase activities in the brain of rats infused intracerebroventricularly with beta-amyloid 1-40. , 2002, Life sciences.

[111]  C Eisdorfer,et al.  Music therapy increases serum melatonin levels in patients with Alzheimer's disease. , 1999, Alternative therapies in health and medicine.

[112]  M. Polidori Antioxidant micronutrients in the prevention of age-related diseases. , 2003, Journal of postgraduate medicine.

[113]  P. Barberger‐Gateau,et al.  Association between antioxidant nutritional indicators and the incidence of dementia: results from the PAQUID prospective cohort study , 2003, European Journal of Clinical Nutrition.

[114]  M. Hüll,et al.  Synergistic inhibitory effect of ascorbic acid and acetylsalicylic acid on prostaglandin E2 release in primary rat microglia , 2003, Journal of neurochemistry.

[115]  X. Tang,et al.  Huperzine A attenuates cognitive dysfunction and neuronal degeneration caused by beta-amyloid protein-(1-40) in rat. , 2001, European journal of pharmacology.

[116]  A. Hofman,et al.  Dietary Intake of Antioxidants and Risk of Alzheimer Disease , 2002 .

[117]  A. Raina,et al.  Homocysteine and Alzheimer's disease: a modifiable risk? , 2004, Free radical biology & medicine.

[118]  N. Delibaş,et al.  Malondialdehyde, superoxide dismutase, melatonin, iron, copper, and zinc blood concentrations in patients with Alzheimer disease: cross-sectional study. , 2002, Croatian medical journal.

[119]  B. Harrison,et al.  Effects of a combined extract of Ginkgo biloba and Bacopa monniera on cognitive function in healthy humans , 2004, Human psychopharmacology.

[120]  Zhenxin Zhang,et al.  [Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial]. , 2002, Zhonghua yi xue za zhi.

[121]  K. Prasad,et al.  Risk Factors for Alzheimer’s Disease: Role of Multiple Antioxidants, Non-Steroidal Anti-inflammatory and Cholinergic Agents Alone or in Combination in Prevention and Treatment , 2002, Journal of the American College of Nutrition.

[122]  K. Charlton,et al.  Lowered plasma vitamin C, but not vitamin E, concentrations in dementia patients. , 2004, The journal of nutrition, health & aging.

[123]  M. Beal Mitochondria, Oxidative Damage, and Inflammation in Parkinson's Disease , 2003, Annals of the New York Academy of Sciences.

[124]  Brian J Bacskai,et al.  In Vivo Imaging of Reactive Oxygen Species Specifically Associated with Thioflavine S-Positive Amyloid Plaques by Multiphoton Microscopy , 2003, The Journal of Neuroscience.

[125]  M. Parle,et al.  Ascorbic Acid: a promising memory-enhancer in mice. , 2003, Journal of pharmacological sciences.

[126]  V. Solfrizzi,et al.  The role of diet in cognitive decline , 2003, Journal of Neural Transmission.

[127]  J. Hong,et al.  A double-blind crossover study evaluating the efficacy of korean red ginseng in patients with erectile dysfunction: a preliminary report. , 2002, The Journal of urology.

[128]  M. di Luca,et al.  Ginkgo biloba extract: from molecular mechanisms to the treatment of Alzhelmer's disease. , 2002, Cellular and molecular biology.

[129]  K. Prasad,et al.  Multiple antioxidants in the prevention and treatment of Alzheimer disease: analysis of biologic rationale. , 2000, Clinical neuropharmacology.

[130]  B. Halliwell,et al.  Iron, Atherosclerosis, and Neurodegeneration: A Key Role for Cholesterol in Promoting Iron‐Dependent Oxidative Damage? , 2004, Annals of the New York Academy of Sciences.

[131]  P. Mecocci,et al.  Plasma susceptibility to free radical-induced antioxidant consumption and lipid peroxidation is increased in very old subjects with Alzheimer disease. , 2002, Journal of Alzheimer's disease : JAD.

[132]  Sonia Trombino,et al.  Antioxidant effect of ferulic acid in isolated membranes and intact cells: synergistic interactions with alpha-tocopherol, beta-carotene, and ascorbic acid. , 2004, Journal of agricultural and food chemistry.

[133]  Satoru Kobayashi,et al.  Animal model of dementia induced by entorhinal synaptic damage and partial restoration of cognitive deficits by BDNF and carnitine , 2002, Journal of neuroscience research.

[134]  B. Winblad,et al.  An active and socially integrated lifestyle in late life might protect against dementia , 2004, The Lancet Neurology.

[135]  C. Shults Coenzyme Q10 in neurodegenerative diseases. , 2003, Current medicinal chemistry.

[136]  A John,et al.  Differential modulation of growth and glutathione metabolism in cultured rat astrocytes by 4-hydroxynonenal and green tea polyphenol, epigallocatechin-3-gallate. , 2002, Neurotoxicology.

[137]  P. Shah,et al.  Differential Effects of Green Tea–Derived Catechin on Developing Versus Established Atherosclerosis in Apolipoprotein E–Null Mice , 2004, Circulation.

[138]  P. Knipschild,et al.  Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial. , 2003, Journal of clinical epidemiology.

[139]  V. Adhami,et al.  Antioxidants of the beverage tea in promotion of human health. , 2004, Antioxidants & redox signaling.

[140]  C. Borek,et al.  Antioxidant health effects of aged garlic extract. , 2001, The Journal of nutrition.

[141]  F. Lezoualc’h,et al.  N‐acetyl‐serotonin (normelatonin) and melatonin protect neurons against oxidative challenges and suppress the activity of the transcription factor NF‐κB , 1998, Journal of pineal research.

[142]  P. Zandi,et al.  Dementia: The leading predictor of death in a defined elderly population , 2004, Neurology.

[143]  J. V. Smith,et al.  Studies on molecular mechanisms of Ginkgo biloba extract , 2004, Applied Microbiology and Biotechnology.

[144]  F. Clostre [Ginkgo biloba extract (EGb 761). State of knowledge in the dawn of the year 2000]. , 1999, Annales pharmaceutiques francaises.

[145]  A. Klugman,et al.  Alpha lipoic acid for dementia. , 2004, The Cochrane database of systematic reviews.

[146]  Amitava Das,et al.  A comparative study in rodents of standardized extracts of Bacopa monniera and Ginkgo biloba Anticholinesterase and cognitive enhancing activities , 2002, Pharmacology Biochemistry and Behavior.

[147]  A. Takashima,et al.  Potent anti‐amyloidogenic and fibril‐destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease , 2003, Journal of neurochemistry.

[148]  H. Arai,et al.  [A new interventional strategy for Alzheimer's disease by Japanese herbal medicine]. , 2000, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

[149]  R. Mayeux,et al.  Antioxidant vitamin intake and risk of Alzheimer disease. , 2003, Archives of neurology.

[150]  R. Ravid,et al.  Molecular changes underlying reduced pineal melatonin levels in Alzheimer disease: alterations in preclinical and clinical stages. , 2003, The Journal of clinical endocrinology and metabolism.

[151]  M. Grundman,et al.  Antioxidant strategies for Alzheimer's disease , 2002, Proceedings of the Nutrition Society.

[152]  G. Perry,et al.  Sources and mechanisms of cytoplasmic oxidative damage in Alzheimer's disease. , 2004, Acta neurobiologiae experimentalis.

[153]  S. Mandel,et al.  Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (‐)‐epigallocatechin‐3‐gallate: implications for neurodegenerative diseases , 2004 .

[154]  P. Doraiswamy Non-cholinergic strategies for treating and preventing Alzheimer's disease. , 2002, CNS drugs.

[155]  R. Bolli,et al.  New perspectives on vitamin E: γ-tocopherol and carboxyethylhydroxychroman metabolites in biology and medicine , 2004 .

[156]  E. Seifritz,et al.  Red Wine Ingredient Resveratrol Protects from β-Amyloid Neurotoxicity , 2003, Gerontology.

[157]  J. Miquel,et al.  The curcuma antioxidants: pharmacological effects and prospects for future clinical use. A review. , 2002, Archives of gerontology and geriatrics.

[158]  G. Perry,et al.  Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease. , 2000, Antioxidants & redox signaling.

[159]  J. Saver,et al.  Combination Therapies and the Theoretical Limits of Evidence-Based Medicine , 2001, Neuroepidemiology.

[160]  V. Srinivasan Melatonin oxidative stress and neurodegenerative diseases. , 2002, Indian journal of experimental biology.

[161]  R. W. Gracy,et al.  Reactive oxygen species: the unavoidable environmental insult? , 1999, Mutation research.

[162]  N. Chainani-Wu Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). , 2003, Journal of alternative and complementary medicine.

[163]  D. Butterfield,et al.  Vitamin E Prevents Alzheimer's Amyloid beta-Peptide (1-42)-Induced Neuronal Protein Oxidation and Reactive Oxygen Species Production. , 2000, Journal of Alzheimer's disease : JAD.

[164]  H. Singh,et al.  Adaptogenic effect of Bacopa monniera (Brahmi) , 2003, Pharmacology Biochemistry and Behavior.

[165]  P. Riederer,et al.  Alpha-lipoic acid as a new treatment option for Alzheimer [corrected] type dementia. , 2001, Archives of gerontology and geriatrics.

[166]  Kohan,et al.  Peripheral markers of oxidative stress in probable Alzheimer patients , 1999, European journal of clinical investigation.

[167]  Andrew Jenner,et al.  Characterization of antioxidant and antiglycation properties and isolation of active ingredients from traditional chinese medicines. , 2004, Free radical biology & medicine.

[168]  P. Mecocci,et al.  Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease , 2003, Neurobiology of Aging.

[169]  Kenjiro Ono,et al.  Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro , 2004, Journal of neuroscience research.

[170]  S. Kanowski,et al.  Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial. , 2003, Pharmacopsychiatry.

[171]  H. Buschke,et al.  Leisure activities and the risk of dementia in the elderly. , 2003, The New England journal of medicine.